Tevogen Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Tevogen Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- TVGN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001860871
Board of directors
-
Avinash R. Wadhwani · DirectorSince 2023
-
Curtis L. Patton · DirectorSince 2024
-
Donald G. Fell · DirectorSince 2023
-
Jeffrey L. Feike · DirectorSince 2024
-
Keow Lin Goh · DirectorSince 2024
-
Michael L. Peterson · DirectorSince 2023
-
Ryan H. Saadi · Director · Chief Executive OfficerSince 2024
-
Scott Harris Sussman · DirectorSince 2023
-
Surendra K. Ajjarapu · Director · CEO and ChairmanSince 2023
-
Susan M. Podlogar · DirectorSince 2024
-
Victor J. Sordillo · DirectorSince 2024
Chief executives
Ryan H. Saadi
· Chief Executive Officer
Since February 2024
Surendra K. Ajjarapu
· CEO and Chairman
2023 – 2024
· Former
Board connections
4 of this board's directors also sit on 3 other boards.
- via Avinash R. Wadhwani, Donald G. Fell, Michael L. Peterson and Surendra K. Ajjarapu
- via Michael L. Peterson and Surendra K. Ajjarapu
- via Michael L. Peterson
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 2024 | Desai Kirti Officer (Chief Financial Officer) | Open-market purchase | +3,000 | $0.82 | $2,460 |
| Jun 5, 2024 | Ryan H. Saadi Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +2,607 | $0.77 | $2,008 |
| Feb 14, 2024 | Desai Kirti Officer (Chief Financial Officer) | Grant or award | +9,696,186 | — | — |
| Feb 14, 2024 | Keow Lin Goh Director | Grant or award | +193,923 | — | — |
| Feb 14, 2024 | Curtis L. Patton Director | Grant or award | +969,618 | — | — |
| Feb 14, 2024 | Ryan H. Saadi Director, Officer (Chief Executive Officer), 10% owner | Grant or award | +98,901,098 | — | — |
| Feb 14, 2024 | Susan M. Podlogar Director | Grant or award | +193,923 | — | — |
| Feb 14, 2024 | Victor J. Sordillo Director | Grant or award | +96,962 | — | — |
| Feb 14, 2024 | Jeffrey L. Feike Director | Grant or award | +581,771 | — | — |
| Feb 14, 2024 | Flomenberg Neal Officer (Chief Scientific Officer) | Grant or award | +5,332,902 | — | — |
| Feb 14, 2024 | Khan Sadiq Officer (Chief Commercial Officer) | Grant or award | +969,618 | — | — |
| Feb 14, 2024 | Ryan H. Saadi Director, Officer (Chief Executive Officer), 10% owner | Grant or award | +19,348,954 | — | — |
| Feb 14, 2024 | Ryan H. Saadi Director, Officer (Chief Executive Officer), 10% owner | Grant or award | +193,923 | — | — |
| Jul 17, 2023 | Corbin ERISA Opportunity Fund, Ltd. 10% owner | Open-market sale | −603,200 | $10.68 | $6,442,176 |
| Jul 17, 2023 | Corbin ERISA Opportunity Fund, Ltd. 10% owner | Open-market sale | −1,716,800 | $10.68 | $18,335,424 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.